Funding news
20n Bio logo

20n Bio Raises $7.5M Seed Round

Recently funded · $7.5M SeedHospitals and Health CareUSView source

Get the full 20n Bio company profile

Access contacts, investors, buying signals & more

Open in Dashboard

The pursuit of novel peptide therapeutics just received a significant boost, with Malvern, PA-based 20n Bio announcing it has secured $7.5M in seed funding. Launched in 2021, the VC-backed startup is dedicated to designing and screening cyclic peptides, aiming to address unmet medical needs.

20n Bio leverages high-throughput screening and computing to generate peptide drugs with desired biophysical, functional, and pharmacological properties, a strategy it hopes will unlock new solutions for complex health challenges.

Other United States companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
Illumina logo

Illumina

United States

$7.1B
4
GRAIL logo

GRAIL

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Seed rounds

Companies that recently closed a Seed round.

#CompanyAmount
1
Coachbetter logo

Coachbetter

Switzerland

$8.2M
2
Forus logo

Forus

France

$6.0M
3
GENI logo

GENI

$8.0M
4
Century Health logo

Century Health

$5.0M
5
CVRD Health logo

CVRD Health

United States

$5.0M